Skip to content
HeyJared

CAP Today

CAP Today is a specialized, professional news outlet focused on pathology and laboratory medicine, serving practicing pathologists, laboratory directors, and diagnostic professionals.

Outlet · Official site

Indexed articles, last 90 days
193
Latest publication
Sep 29, 2026
Audience
Top 5M sites
Earliest in this view
Jul 6, 2026

Latest articles

  1. Article · Sep 29, 2026 · CAP TODAY

    Assessment of HbA1c in Patients with Hemoglobin Variants (opens the original)

    Excerpt

    Read excerpt

    September 2026—This discussion is part of a series of one-on-one virtual roundtables in which CAP TODAY publisher Bob McGonnagle speaks with one vendor and one laboratory expert to spotlight a company and a customer for their laboratory solutions and work. He spoke on September 23, 2026 with David Sacks MB, ChB, FRCPath, Chairman, Steering Committee, National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience Inc. [caption

  2. Article · Sep 29, 2026 · CAP TODAY

    FDA clears Cepheid Xpert Respiratory panel (opens the original)

    Excerpt · Positive tone

    Read excerpt

    Sept. 29, 2026—Cepheid has received FDA clearance for the Xpert Respiratory panel, a multiplex PCR test designed to detect 13 common viral and bacterial respiratory pathogens from a single nasopharyngeal swab sample. The post FDA clears Cepheid Xpert Respiratory panel appeared first on CAP TODAY.

  3. Article · Sep 28, 2026 · CAP TODAY

    FDA clears QIAstat-Dx bacteria detection panel (opens the original)

    Excerpt

    Read excerpt

    Sept. 28, 2026—The Food and Drug Administration has cleared Qiagen’s QIAstat-Dx BCID GN Plus AMR panel. The post FDA clears QIAstat-Dx bacteria detection panel appeared first on CAP TODAY.

  4. Article · Sep 25, 2026 · Keith Eilers

    RAS in Action: From a Single Mutation to a Targeted Class-September 24, 2026 (opens the original)

    Excerpt

    Read excerpt

    Webinar presenters Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian, and David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyte

  5. Article · Sep 18, 2026 · CAP TODAY

    Project Santa Fe Foundation adds three board members (opens the original)

    Excerpt · Neutral tone

    Read excerpt

    Sept. 18, 2026—Project Santa Fe Foundation and Clinical Lab 2.0 have added three new members to its board of directors: Mercè Jordà, MD, PhD, MBA, chair of pathology and laboratory medicine, University of Miami Miller School of Medicine; William G. Morice, MD, PhD, president and CEO, Mayo Collaborative Services/Mayo Clinic Laboratories; and Peter Weir, MD, MPH, chief population health officer, University of Utah Health. The post Project Santa Fe Foundation adds three board members appeared first

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 5M sites

Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

How this was measured

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about CAP Today